The influence of curcumin, quercetin, and eicosapentaenoic acid on the expression of phase II detoxification enzymes in the intestinal cell lines HT-29, Caco-2, HuTu 80, and LT97

Nutrition and Cancer

Volumn 64, Issue 6, 2012, Pages 856-863

  Odenthal, Julia ^a   Van Heumen, Bjorn W H ^a   Roelofs, Hennie M J ^a   Te Morsche, Rene H M ^a   Marian, Brigitte ^b   Nagengast, Fokko M ^a   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; ICOSAPENTAENOIC ACID; QUERCETIN;

ADENOMATOUS POLYP; ARTICLE; CANCER CELL; COLON ADENOMA; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE CANCER; INTESTINE CELL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

ADENOMA; CACO-2 CELLS; CELL LINE; COLONIC NEOPLASMS; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HT29 CELLS; HUMANS; INTESTINAL NEOPLASMS; METABOLIC DETOXICATION, PHASE II; QUERCETIN;

EID: 84865220442     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.700994     Document Type: Article

References (54)

1. Fearnhead, N S, Britton, M P, and, Bodmer, W F. 2001. The ABC of APC. Hum Mol Genet, 10: 721-733. (Pubitemid 32331581)
2. Vasen, H F, Moslein, G, Alonso, A, Aretz, S, and, Bernstein, I. 2008. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut, 57: 704-713. (Pubitemid 351579987)
3. Giardiello, F M, Hamilton, S R, Krush, A J, Piantadosi, S, and, Hylind, LM. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med, 328: 1313-1316. (Pubitemid 23131373)
4. Phillips, R K, Wallace, M H, Lynch, P M, Hawk, E, and, Gordon, GB. 2002. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut, 50: 857-860. (Pubitemid 34539050)
5. Villegas, I, Sanchez-Fidalgo, S, and, Alarcón de la Lastra, C. 2008. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res, 52: 1040-1061.
6. Solomon, S D, McMurray, J J, Pfeffer, M A, Wittes, J, and, Fowler, R. 2005. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med, 352: 1071-1080. (Pubitemid 40365348)
7. Cruz-Correa, M, Hylind, L M, Romans, K E, Booker, S V, and, Giardiello, F M. 2002. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology, 122: 641-645. (Pubitemid 34173815)
8. Lev-Ari, S, Strier, L, Kazanov, D, Madar-Shapiro, L, and, Dvory-Sobol, H. 2005. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res, 11: 6738-6744. (Pubitemid 41339017)
9. Lee, Y K, Park, S Y, Kim, Y M, Lee, W S, and, Park, O J. 2009. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp Mol Med, 41: 201-207.
10. Calviello, G, Di, N F, Gragnoli, S, Piccioni, E, and, Serini, S. 2004. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and-2 and HIF-1alpha induction pathway. Carcinogenesis, 25: 2303-2310. (Pubitemid 39625169)
11. Shehzad, A, Wahid, F, and, Lee, Y S. 2010. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim), 343: 489-499.
12. Cruz-Correa, M, Shoskes, D A, Sanchez, P, Zhao, R, and, Hylind, LM. 2006. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol, 4: 1035-1038. (Pubitemid 44118839)
13. Bischoff, S C. 2008. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care, 11: 733-740.
14. Murphy, E A, Davis, J M, McClellan, J L, and, Carmichael, M D. 2011. Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min/+) mouse. Nutr Cancer, 63: 421-426.
15. Fini, L, Piazzi, G, Ceccarelli, C, Daoud, Y, and, Belluzzi, A. 2010. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice. Clin Cancer Res, 16: 5703-5711.
16. Minoura, T, Takata, T, Sakaguchi, M, Takada, H, and, Yamamura, M. 1988. Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res, 48: 4790-4794.
17. Paulsen, J E, Elvsaas, I K, Steffensen, I L, and, Alexander, J. 1997. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis, 18: 1905-1910. (Pubitemid 28132373)
18. West, N J, Clark, S K, Phillips, R K, Hutchinson, JM, and, Leicester, RJ. 2010. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut, 59: 918-925.
19. Nijhoff, W A, Groen, G M, and, Peters, W HM. 1993. Induction of rat hepatic and intestinal glutathione s-transferases and glutathione by dietary naturally-occurring anticarcinogens. Int J Oncol, 3: 1131-1139. (Pubitemid 23361374)
20. Wiegand, H, Boesch-Saadatmandi, C, Regos, I, Treutter, D, Wolffram, S. 2009. Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats. Nutr Cancer, 61: 717-722.
21. van der Logt, E MJ, Roelofs, H MJ, Nagengast, F M, and, Peters, W HM. 2003. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis, 24: 1651-1656. (Pubitemid 37304670)
22. Caputo, M, Zirpoli, H, Torino, G, and, Tecce, M F. 2011. Selective regulation of UGT1A1 and SREBP-1c mRNA expression by docosahexaenoic, eicosapentaenoic, and arachidonic acids. J Cell Physiol, 226: 187-193.
23. van Beelen, V A, Aarts, J M, Reus, A, Mooibroek, H, and, Sijtsma, L. 2006. Differential induction of electrophile-responsive element-regulated genes by n-3 and n-6 polyunsaturated fatty acids. FEBS Lett, 580: 4587-4590. (Pubitemid 44189373)
24. Hayes, J D, and, Pulford, D J. 1995. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30: 445-600.
25. Tukey, R H, and, Strassburg, C P. 2000. Human UDP- glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol, 40: 581-616. (Pubitemid 30340694)
26. Wargovich, M J. 1997. Experimental evidence for cancer preventive elements in foods. Cancer Lett, 114: 11-17. (Pubitemid 27140066)
27. Talalay, P. 2000. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors, 12: 5-11. (Pubitemid 32107378)
28. Richter, M, Jurek, D, Wrba, F, Kaserer, K, Wurzer, G. 2002. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer, 38: 1937-1945. (Pubitemid 35247480)
29. Lowry, O H, Rosebrough, N J, Farral, A L, and, Randall, R J. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem, 193: 265-275.
30. Peters, W HM, Allebes, W A, Jansen, P LM, Poels, L G, and, Capel, P J. 1987. Characterization and tissue specificity of a monoclonal antibody against human uridine 5-diphosphate-glucuronosyltransferase. Gastroenterology, 93: 162-169. (Pubitemid 17084109)
31. Peters, W HM, Nagengast, F M, and, Wobbes, T. 1989. Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis, 10: 2371-2374. (Pubitemid 20009125)
32. Peters, W HM, Kock, L, Nagengast, F M, and, Roelofs, H MJ. 1990. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol, 39: 591-597. (Pubitemid 20041930)
33. Peters, W HM, Boon, C E, Roelofs, H MJ, Wobbes, T, Nagengast, F M. 1992. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103: 448-455.
34. Habig, W H, Pabst, M J, and, Jakoby, W B. 1974. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem, 249: 7130-7139.
35. Raijmakers, M TM, Zusterzeel, P LM, Steegers, E AP, Hectors, M P, Demacker, P N. 2000. Plasma thiol status in preeclampsia. Obstet Gynecol, 95: 180-184. (Pubitemid 30045636)
36. Peters, W HM, Roelofs, H MJ, Hectors, M P, Nagengast, F M, and, Jansen, JBMJ. 1993. Glutathione and glutathione S-transferases in Barrett's epithelium. Br J Cancer, 67: 1413-1417. (Pubitemid 23172889)
37. Ritchie, K J, Walsh, S, Sansom, O J, Henderson, C J, and, Wolf, C R. 2009. Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase pi. Proc Natl Acad Sci USA, 106: 20859-20864.
38. Nakae, D, Denda, A, Kobayashi, Y, Akai, H, and, Kishida, H. 1998. Inhibition of early-phase exogenous and endogenous liver carcinogenesis in transgenic rats harboring a rat glutathione S-transferase placental form gene. Jpn J Cancer Res, 89: 1118-1125. (Pubitemid 29007992)
39. van der Logt, E MJ, Bergevoet, S M, Roelofs, H MJ, van Hooijdonk, Z, and, te Morsche, RHM. 2004. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis, 25: 2407-2415. (Pubitemid 39625181)
40. Berkhout, M, Roelofs, H MJ, te Morsche, R HM, Dekker, E, and, Van Krieken, JHJM. 2008. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis. Br J Surg, 95: 499-505.
41. Berger, S J, Gosky, D, Zborowska, E, Willson, J K, and, Berger, N A. 1994. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Cancer Res, 54: 4077-4083. (Pubitemid 24258112)
42. Van Erk, M J, Teuling, E, Staal, Y C, Huybers, S, and, Van Bladeren, PJ. 2004. Time-and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog, 3: 8
43. Giros, A, Grzybowski, M, Sohn, V R, Pons, E, and, Fernandez-Morales, J. 2009. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids docosahexaenoic and eicosapentaenoic. Cancer Prev Res (Phila), 2: 732-742.
44. Schaefer, S, Baum, M, Eisenbrand, G, Dietrich, H, Will, F. 2006. Polyphenolic apple juice extracts and their major constituents reduce oxidative damage in human colon cell lines. Mol Nutr Food Res, 50: 24-33. (Pubitemid 43158371)
45. Ye, S F, Hou, Z Q, Zhong, L M, and, Zhang, Q Q. 2007. Effect of curcumin on the induction of glutathione S-transferases and NADP(H):quinone oxidoreductase and its possible mechanism of action. Yao Xue Xue Bao, 42: 376-380.
46. Bellion, P, Olk, M, Will, F, Dietrich, H, and, Baum, M. 2009. Formation of hydrogen peroxide in cell culture media by apple polyphenols and its effect on antioxidant biomarkers in the colon cell line HT-29. Mol Nutr Food Res, 53: 1226-1236.
47. Latham, P, Lund, E K, Brown, J C, and, Johnson, I T. 2001. Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. Gut, 49: 97-105. (Pubitemid 32601886)
48. Petri, N, Tannergren, C, Holst, B, Mellon, FA, and, Bao, Y. 2003. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos, 31: 805-813. (Pubitemid 36617672)
49. Galijatovic, A, Walle, U K, and, Walle, T. 2000. Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells. Pharm Res, 17: 21-26. (Pubitemid 30121094)
50. Sambuy, Y, De, A I, Ranaldi, G, Scarino, M L, Stammati, A. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol, 21: 1-26. (Pubitemid 40767684)
51. Peters, W HM, and, Roelofs, H MJ. 1989. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J, 264: 613-616. (Pubitemid 20024537)
52. Habermann, N, Lund, E K, Pool-Zobel, B L, and, Glei, M. 2009. Modulation of gene expression in eicosapentaenoic acid and docosahexaenoic acid treated human colon adenoma cells. Genes Nutr, 4: 73-76.
53. Goel, A, Boland, C R, and, Chauhan, D P. 2001. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett, 172: 111-118. (Pubitemid 32889704)
54. Ferraresi, R, Troiano, L, Roat, E, Lugli, E, and, Nemes, E. 2005. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res, 39: 1249-1258. (Pubitemid 41601428)